Effect of labetalol for treating patients with pregnancy-induced hypertension: A systematic review

Effect of labetalol for treating patients with pregnancy-induced hypertension: A systematic review

Pregnancy-induced hypertension (PIH) is one of the main causes of maternal mortality. Many first- and second-line drugs are available to treat the condition. Labetalol lowers blood pressure by blocking both α and β adrenergic receptors. It preserves uteroplacental blood flow efficiently. A systemic...

Full description

Bibliographic Details
Main Authors: Punyatoya Bej, Sambhunath Das
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Journal of the Practice of Cardiovascular Sciences
Subjects:
eclampsia
fetal outcome
labetalol
maternal outcome
nifedipine
preeclampsia
pregnancy-induced hypertension
Online Access:http://www.j-pcs.org/article.asp?issn=2395-5414;year=2022;volume=8;issue=3;spage=144;epage=151;aulast=Bej

Internet

http://www.j-pcs.org/article.asp?issn=2395-5414;year=2022;volume=8;issue=3;spage=144;epage=151;aulast=Bej

Similar Items